Home | Welcome to Contract Pharma   
Last Updated Tuesday, July 22 2014
Print

Breaking News

Related Searches:
January 20, 2011
Genzyme Corp. will build an additional manufacturing plant in Geel, Belgium, to support the long-term growth of Myozyme and Lumizyme for Pompe disease.  Read More »
January 20, 2011
Evotec AG has entered into a collaboration with Takeda Cambridge Ltd., to identify small molecule modulators against GPCR and Protease targets to treat various CNS and Metabolic diseases.  Read More »
January 20, 2011
inVentiv Health has signed a definitive agreement to acquire the i3 clinical development businesses from Ingenix.  Read More »
January 20, 2011
BioClinica, Inc. has established a strategic partnership with Symbiance Inc., a specialty CRO based in Princeton, NJ.   Read More »
January 20, 2011
Roger N. Hayes, Ph.D., has been appointed president of Bioanalytical Operations at Cetero Research.  Read More »
January 19, 2011
Amgen and Boehringer Ingelheim have signed an agreement under which Boehringer will acquire the rights to, and the assets of, Amgen's Fremont CA development and manufacturing facility.  Read More »
January 19, 2011
Sanofi-Aventis and Famar have entered an agreement under which Famar will integrate Sanofi’s plant in Madrid, into its network of 11 sites across Europe.  Read More »
January 19, 2011
Terence Novak has been appointed president of commercial operations for Norwich Pharmaceuticals.  Read More »
January 19, 2011
Dr. Anthony Priestley has been appointed medical director at ICON’s Clinical Pharmacology Unit in Manchester, UK.  Read More »
January 18, 2011
PharmaForm has hired of several key scientists and invested in equipment for expansion plans in 2011.   Read More »
January 18, 2011
Cambrex Corp. has received GMP compliance certification from the Danish Medicines Agency (DKMA) for its manufacturing site in Hyderabad, India, following an audit conducted in October 2010.  Read More »
January 18, 2011
INC Research has acquired AVOS Life Sciences.   Read More »
January 18, 2011
Dave Hammond has joined QPharma, Inc. as vice president of sales and marketing.  Read More »
January 17, 2011
Catalent Pharma Solutions is adding to its global network of sourcing specialists to supply comparator drugs directly from manufacturers in an effort to reduce customer costs and ensure timely initiation and reliability of product supply.  Read More »
January 17, 2011
Abbott Laboratories has withdrawn its centralized marketing authorization application with Europe’s EMA for Ozespa, briakinumab, 100 mg solution for injection, for the treatment of moderate to severe chronic plaque psoriasis in adults who failed to   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On